KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
FRA:YMP3
Delisted

Symphony Holdings Limited Stock Price (Quote)

Frankfurt Stock Exchange
Open Broker Account
0.0890€
+0 (+0%)
At Close: Aug 17, 2022
Forecast Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days 0.0890€ 0.0890€ Wednesday, 17th Aug 2022 YMP3.F stock ended at 0.0890€. During the day the stock fluctuated 0% from a day low at 0.0890€ to a day high of 0.0890€.
90 days 0.0890€ 0.0890€
52 weeks 0.0890€ 0.0905€

Historical Symphony Holdings Limited prices

Date Open High Low Close Volume
Sep 20, 2019 0.0895€ 0.0895€ 0.0895€ 0.0895€ 22 500
Sep 19, 2019 0.0909€ 0.0909€ 0.0909€ 0.0909€ 22 500
Sep 18, 2019 0.0896€ 0.0896€ 0.0896€ 0.0896€ 22 500
Sep 17, 2019 0.0913€ 0.0913€ 0.0913€ 0.0913€ 22 500
Sep 16, 2019 0.0907€ 0.0907€ 0.0907€ 0.0907€ 22 500
Sep 13, 2019 0.0916€ 0.0916€ 0.0916€ 0.0916€ 22 500
Sep 12, 2019 0.0911€ 0.0911€ 0.0911€ 0.0911€ 22 500
Sep 11, 2019 0.0918€ 0.0918€ 0.0918€ 0.0918€ 22 500
Sep 10, 2019 0.0918€ 0.0918€ 0.0918€ 0.0918€ 22 500
Sep 09, 2019 0.0920€ 0.0920€ 0.0920€ 0.0920€ 22 500
Sep 06, 2019 0.0919€ 0.0919€ 0.0919€ 0.0919€ 22 500
Sep 05, 2019 0.0924€ 0.0928€ 0.0924€ 0.0928€ 22 500
Sep 04, 2019 0.0924€ 0.0933€ 0.0924€ 0.0933€ 0
Sep 03, 2019 0.0928€ 0.0928€ 0.0928€ 0.0928€ 0
Sep 02, 2019 0.0923€ 0.0923€ 0.0923€ 0.0923€ 0
Aug 29, 2019 0.0926€ 0.0926€ 0.0926€ 0.0926€ 0
Aug 28, 2019 0.0925€ 0.0925€ 0.0925€ 0.0925€ 0
Aug 27, 2019 0.0960€ 0.0960€ 0.0924€ 0.0924€ 22 500
Aug 26, 2019 0.0922€ 0.0922€ 0.0922€ 0.0922€ 0
Aug 23, 2019 0.0940€ 0.0940€ 0.0940€ 0.0940€ 0
Aug 22, 2019 0.0915€ 0.0915€ 0.0915€ 0.0915€ 0
Aug 21, 2019 0.0937€ 0.0937€ 0.0937€ 0.0937€ 0
Aug 20, 2019 0.0926€ 0.0926€ 0.0926€ 0.0926€ 0
Aug 19, 2019 0.0948€ 0.0948€ 0.0948€ 0.0948€ 0
Aug 16, 2019 0.0937€ 0.0937€ 0.0937€ 0.0937€ 0
Click to get the best stock tips daily for free!

About Symphony Holdings Limited

Symphony Holdings Limited Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... YMP3.F Profile

Golden Star

Ticker Date Change Price
DHT Apr 24 2.04% $11.28
MLI Apr 19 9.66% $52.28
LPLA Apr 19 1.42% $262.59
DOOR Apr 18 0.167% $131.39
LNG Apr 17 1.49% $156.81
FCN Apr 16 1.80% $207.62
ELV Apr 16 5.97% $506.97
AKR Apr 05 4.78% $16.53
ITCI Apr 05 7.04% $68.44
VSTS Apr 04 0.425% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT